Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Valuing the Wild: From Stated Preference Methods to Compensating Income Variation

Project description

Why some people pay for wildlife products

The illegal wildlife trade, fuelled by demand for endangered species products in traditional medicine, poses a serious threat to global biodiversity and public health, including the risk of zoonotic disease transmission. Yet, little research has focused on people’s healthcare-related preferences and willingness to pay (WTP) for such products. Supported by the Marie Skłodowska-Curie Actions programme, the WILDVALUE project will assess WTP for both healthcare and endangered wildlife products using the Compensating Income Variation (CIV) method. This pioneering approach will, for the first time, compare CIV with traditional stated preference methods, pushing the boundaries of non-market valuation. The project will provide new insights into consumer behaviour and contribute to improved wildlife trade governance and public health policymaking.

Objective

Demand for endangered wildlife products is driving the illegal and unsustainable wildlife trade, which threatens global biodiversity and has significant impacts on public health through the transmission of zoonotic diseases across the world. The illegal wildlife trade is imperilling one quarter of the total terrestrial vertebrate species, pushing many species to the brink of extinction. The rising frequency of zoonotic epidemics and pandemics, with COVID-19 as the most recent example, has highlighted the devastating public health consequences that can result from wildlife consumption. In many Asian cultures, people use endangered wildlife products as traditional medicine to treat various diseases and health conditions, despite the availability of alternative treatments and modern medicines. Understanding people’s preferences, particularly their willingness to pay (WTP) for healthcare, is critical to inform public health policies and wildlife trade governance. Yet, few studies have been conducted on this important topic due to challenges in approaching consumers and limitations in existing non-market valuation methods, particularly preference-based methods. The two specific aims of WILDVALUE are: (1) to assess people’s preferences for healthcare and endangered wildlife products using the Compensating Income Variation (CIV) method and (2) to advance the field of non-market valuation by comparing the CIV method to stated preference methods for the first time. WILDVALUE will improve wildlife trade governance, inform public health policies, and advance the field of non-market valuation through a unique research on the consumption of endangered wildlife products for health-related purposes.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

HELSINGIN YLIOPISTO
Net EU contribution
€ 242 116,80
Address
FABIANINKATU 33
00014 Helsinki
Finland
Region
Manner-Suomi Helsinki-Uusimaa Helsinki-Uusimaa
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data